Inclusion Criteria:  subjects aged 44 to 53 years; no conditions known to be contraindications to the use of tetracyclines; written informed consent.  Exclusion Criteria:  end stage liver, heart and renal disease, active malignancy, female subjects who are pregnant or lactating